Salt la conţinut

Traumatologie şi medicină de urgenţă

Managementul şi optimizarea hemostazei

Agenți antifibrinolitici

Alternatives to allogeneic platelet transfusion. (se deschide o fereastră nouă)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Sursă‎: Br J Haematol 2016;175(3):381-92.

Index‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (se deschide o fereastră nouă)

Antifibrinolytic drugs for acute traumatic injury. (se deschide o fereastră nouă)

Ker K, Roberts I, Shakur H, Coats TJ.

Sursă‎: Cochrane Database Syst Rev 2015;(5):CD004896.

Index‎: PubMed 25956410

DOI‎: 10.1002/14651858.CD004896.pub4

https://www.ncbi.nlm.nih.gov/pubmed/25956410 (se deschide o fereastră nouă)

Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. (se deschide o fereastră nouă)

Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE.

Sursă‎: JAMA Surg 2013;148(3):218-25.

Index‎: PubMed 23670117

DOI‎: 10.1001/jamasurg.2013.764

https://www.ncbi.nlm.nih.gov/pubmed/23670117 (se deschide o fereastră nouă)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (se deschide o fereastră nouă)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Sursă‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Index‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (se deschide o fereastră nouă)

Factorul VII (rFVIIa) recombinant activat

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (se deschide o fereastră nouă)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Sursă‎: Transfusion 2009;49 Suppl 5:240S-7S.

Index‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (se deschide o fereastră nouă)

Concentrați din factori de coagulare

The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. (se deschide o fereastră nouă)

Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M.

Sursă‎: Injury 2013;44(2):209-16.

Index‎: PubMed 23000050

DOI‎: 10.1016/j.injury.2012.08.047

https://www.ncbi.nlm.nih.gov/pubmed/23000050 (se deschide o fereastră nouă)

Desmopresină

Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury. (se deschide o fereastră nouă)

Furay EJ, Daley MJ, Satarasinghe P, Lara S, Aydelotte JD, Teixeira PG, Coopwood TB, Ali S, Brown CVR

Sursă‎: J Trauma Acute Care Surg 2020;88(1):80-6.

Index‎: PubMed 31688782

DOI‎: 10.1097/TA.0000000000002521

https://www.ncbi.nlm.nih.gov/pubmed/31688782 (se deschide o fereastră nouă)

Teste vâscoelastice pentru identificarea sângerării chirurgicale sau coagulopatice

Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. (se deschide o fereastră nouă)

Brenni M, Worn M, Brüesch M, Spahn DR, Ganter MT.

Sursă‎: Acta Anaesthesiol Scand 2010;54(1):111-7.

Index‎: PubMed 19860752

DOI‎: 10.1111/j.1399-6576.2009.02132.x

https://www.ncbi.nlm.nih.gov/pubmed/19860752 (se deschide o fereastră nouă)